Neuroprotective effect of baicalin on focal cerebral ischemia in rats.

Abstract

Baicalin, a flavonoid compound from the root of the herb Scutellaria baicalensis Georgi, has been widely used to treat patients with inflammatory disease. The aim of this study was to assess the efficacy of baicalin in a rat model of focal cerebral ischemia. Adult male Sprague-Dawley rat models of cerebral artery occlusion were established and then randomly and equally divided into three groups: ischemia (cerebral ischemia and reperfusion), valproic acid (cerebral ischemia and reperfusion + three intraperitoneal injections of valproic acid; positive control), and baicalin (cerebral ischemia and reperfusion + intraperitoneal injection of baicalin for 21 days). Neurological deficits were assessed using the postural reflex test and forelimb placing test at 3, 7, 14, and 21 days after ischemia. Rat cerebral infarct volume was measured using 2,3,5-triphenyltetrazolium chloride (TTC) staining method. Pathological change of ischemic brain tissue was assessed using hematoxylin-eosin staining. In the baicalin group, rat neurological function was obviously improved, cerebral infarct volume was obviously reduced, and the pathological impairment of ischemic brain tissue was obviously alleviated compared to the ischemia group. Cerebral infarct volume was similar in the valproic acid and baicalin groups. These findings suggest that baicalin has a neuroprotective effect on cerebral ischemia.

• Authors: Jiong Dai, Yong-Ming Qiu, Zheng-Wen Ma, Guo-Feng Yan, Jing Zhou, Shan-Quan Li, Hui Wu, Yi-Chao Jin, Xiao-Hua Zhang
• Journal: Neural regeneration research (Neural Regen Res) Vol. 13 Issue 12 Pg. 2129-2133 (Dec 2018) ISSN: 1673-5374 [Print] India
• PMID: 30323141 (Publication Type: Journal Article)